306 related articles for article (PubMed ID: 22574751)
1. Differences in the cellular uptake and intracellular itineraries of amyloid beta proteins 40 and 42: ramifications for the Alzheimer's drug discovery.
Omtri RS; Davidson MW; Arumugam B; Poduslo JF; Kandimalla KK
Mol Pharm; 2012 Jul; 9(7):1887-97. PubMed ID: 22574751
[TBL] [Abstract][Full Text] [Related]
2. Differential Effects of Alzheimer's Disease Aβ40 and 42 on Endocytosis and Intraneuronal Trafficking.
Omtri RS; Thompson KJ; Tang X; Gali CC; Panzenboeck U; Davidson MW; Kalari KR; Kandimalla KK
Neuroscience; 2018 Mar; 373():159-168. PubMed ID: 29337241
[TBL] [Abstract][Full Text] [Related]
3. Amyloid-Beta Peptides 40 and 42 Employ Distinct Molecular Pathways for Cell Entry and Intracellular Transit at the Blood-Brain Barrier Endothelium.
Wang Z; Sharda N; Omtri RS; Li L; Kandimalla KK
Mol Pharmacol; 2023 Nov; 104(5):203-213. PubMed ID: 37541759
[TBL] [Abstract][Full Text] [Related]
4. Mechanism of neuronal versus endothelial cell uptake of Alzheimer's disease amyloid beta protein.
Kandimalla KK; Scott OG; Fulzele S; Davidson MW; Poduslo JF
PLoS One; 2009; 4(2):e4627. PubMed ID: 19247480
[TBL] [Abstract][Full Text] [Related]
5. Alzheimer's disease amyloid β-protein mutations and deletions that define neuronal binding/internalization as early stage nonfibrillar/fibrillar aggregates and late stage fibrils.
Poduslo JF; Howell KG; Olson NC; Ramirez-Alvarado M; Kandimalla KK
Biochemistry; 2012 May; 51(19):3993-4003. PubMed ID: 22545812
[TBL] [Abstract][Full Text] [Related]
6. Perforin Promotes Amyloid Beta Internalisation in Neurons.
Lana E; Khanbolouki M; Degavre C; Samuelsson EB; Åkesson E; Winblad B; Alici E; Lithner CU; Behbahani H
Mol Neurobiol; 2017 Mar; 54(2):874-887. PubMed ID: 26780457
[TBL] [Abstract][Full Text] [Related]
7. Live Cell FRET Imaging Reveals Amyloid β-Peptide Oligomerization in Hippocampal Neurons.
Gao Y; Wennmalm S; Winblad B; Schedin-Weiss S; Tjernberg LO
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33926107
[TBL] [Abstract][Full Text] [Related]
8. Calcium-sensing receptor antagonist (calcilytic) NPS 2143 specifically blocks the increased secretion of endogenous Aβ42 prompted by exogenous fibrillary or soluble Aβ25-35 in human cortical astrocytes and neurons-therapeutic relevance to Alzheimer's disease.
Armato U; Chiarini A; Chakravarthy B; Chioffi F; Pacchiana R; Colarusso E; Whitfield JF; Dal Prà I
Biochim Biophys Acta; 2013 Oct; 1832(10):1634-52. PubMed ID: 23628734
[TBL] [Abstract][Full Text] [Related]
9. Low-density lipoprotein receptor-related protein 1 (LRP1) mediates neuronal Abeta42 uptake and lysosomal trafficking.
Fuentealba RA; Liu Q; Zhang J; Kanekiyo T; Hu X; Lee JM; LaDu MJ; Bu G
PLoS One; 2010 Jul; 5(7):e11884. PubMed ID: 20686698
[TBL] [Abstract][Full Text] [Related]
10. Iron treatment inhibits Aβ42 deposition in vivo and reduces Aβ42/Aβ40 ratio.
Shen X; Liu J; Fujita Y; Liu S; Maeda T; Kikuchi K; Obara T; Takebe A; Sayama R; Takahashi T; Matsue A; Sera K; Michikawa M; Komano H; Zou K
Biochem Biophys Res Commun; 2019 May; 512(4):653-658. PubMed ID: 30791980
[TBL] [Abstract][Full Text] [Related]
11. Aberrant Co-localization of Synaptic Proteins Promoted by Alzheimer's Disease Amyloid-β Peptides: Protective Effect of Human Serum Albumin.
Domínguez-Prieto M; Velasco A; Vega L; Tabernero A; Medina JM
J Alzheimers Dis; 2017; 55(1):171-182. PubMed ID: 27662292
[TBL] [Abstract][Full Text] [Related]
12. Evidence that Brain-Reactive Autoantibodies Contribute to Chronic Neuronal Internalization of Exogenous Amyloid-β1-42 and Key Cell Surface Proteins During Alzheimer's Disease Pathogenesis.
Goldwaser EL; Acharya NK; Wu H; Godsey GA; Sarkar A; DeMarshall CA; Kosciuk MC; Nagele RG
J Alzheimers Dis; 2020; 74(1):345-361. PubMed ID: 32039847
[TBL] [Abstract][Full Text] [Related]
13. Distinct Uptake Kinetics of Alzheimer Disease Amyloid-
Sharda N; Ahlschwede KM; Curran GL; Lowe VJ; Kandimalla KK
J Pharmacol Exp Ther; 2021 Mar; 376(3):482-490. PubMed ID: 33303699
[TBL] [Abstract][Full Text] [Related]
14. Apolipoprotein E and low density lipoprotein receptor-related protein facilitate intraneuronal Abeta42 accumulation in amyloid model mice.
Zerbinatti CV; Wahrle SE; Kim H; Cam JA; Bales K; Paul SM; Holtzman DM; Bu G
J Biol Chem; 2006 Nov; 281(47):36180-6. PubMed ID: 17012232
[TBL] [Abstract][Full Text] [Related]
15. Upregulation of CRABP1 in human neuroblastoma cells overproducing the Alzheimer-typical Abeta42 reduces their differentiation potential.
Uhrig M; Brechlin P; Jahn O; Knyazev Y; Weninger A; Busia L; Honarnejad K; Otto M; Hartmann T
BMC Med; 2008 Dec; 6():38. PubMed ID: 19087254
[TBL] [Abstract][Full Text] [Related]
16. Protease inhibitor coinfusion with amyloid beta-protein results in enhanced deposition and toxicity in rat brain.
Frautschy SA; Horn DL; Sigel JJ; Harris-White ME; Mendoza JJ; Yang F; Saido TC; Cole GM
J Neurosci; 1998 Oct; 18(20):8311-21. PubMed ID: 9763475
[TBL] [Abstract][Full Text] [Related]
17. Detection of amyloid plaques by radioligands for Abeta40 and Abeta42: potential imaging agents in Alzheimer's patients.
Kung MP; Skovronsky DM; Hou C; Zhuang ZP; Gur TL; Zhang B; Trojanowski JQ; Lee VM; Kung HF
J Mol Neurosci; 2003 Feb; 20(1):15-24. PubMed ID: 12663930
[TBL] [Abstract][Full Text] [Related]
18. Targeting the alpha 7 nicotinic acetylcholine receptor to reduce amyloid accumulation in Alzheimer's disease pyramidal neurons.
D'Andrea MR; Nagele RG
Curr Pharm Des; 2006; 12(6):677-84. PubMed ID: 16472157
[TBL] [Abstract][Full Text] [Related]
19. Apolipoprotein E4 promotes the early deposition of Abeta42 and then Abeta40 in the elderly.
Walker LC; Pahnke J; Madauss M; Vogelgesang S; Pahnke A; Herbst EW; Stausske D; Walther R; Kessler C; Warzok RW
Acta Neuropathol; 2000 Jul; 100(1):36-42. PubMed ID: 10912918
[TBL] [Abstract][Full Text] [Related]
20. The coexistence of an equal amount of Alzheimer's amyloid-β 40 and 42 forms structurally stable and toxic oligomers through a distinct pathway.
Chang YJ; Chen YR
FEBS J; 2014 Jun; 281(11):2674-87. PubMed ID: 24720730
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
